» Articles » PMID: 3815358

Molecular Dosimetry of O4-ethyldeoxythymidine in Rats Continuously Exposed to Diethylnitrosamine

Overview
Journal Cancer Res
Specialty Oncology
Date 1987 Mar 15
PMID 3815358
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

There is considerable interest in incorporating mechanistically based biological data into the process of quantitative risk assessment. Presently, no adequate data bases for internal dosimeters, such as DNA adducts, exist for humans or experimental animals. Therefore, the major promutagenic ethyl adduct, O4-ethyldeoxythymidine (O4-EtdT), has been quantitated in liver DNA after continuous exposure of rats to drinking water containing 0.4, 1, 4, 10, 40, or 100 ppm diethylnitrosamine (DEN) for 1, 4, 7, 14, 28, 49, or 70 days. The rate of O4-EtdT accumulation was modeled as the difference between a DEN-dependent rate of formation and an O4-EtdT concentration-dependent rate of loss. In general, O4-EtdT concentrations increased rapidly during the first 7 days of exposure and by 7-28 days O4-EtdT had accumulated to apparent steady-state concentrations that were DEN concentration-dependent over the entire dose range. The concentration of the adduct increased with DEN concentration over the entire dose range for exposures of 28 days or less and for doses of 0.4 to 40 ppm DEN the adduct level increased with DEN concentration for exposures of 70 days or less. Although the dose response of O4-EtdT was relatively linear, with increasing DEN concentration a trend toward a less than linear relationship was observed. This suggests that there was a lower efficiency of formation and/or greater loss of O4-EtdT during high-dose exposures. This study provides a data base that can be used to qualitatively and quantitatively examine the relationship between external dose and O4-EtdT over a DEN dose range covering several orders of magnitude.

Citing Articles

Metabolic Activation and DNA Interactions of Carcinogenic -Nitrosamines to Which Humans Are Commonly Exposed.

Li Y, Hecht S Int J Mol Sci. 2022; 23(9).

PMID: 35562949 PMC: 9105260. DOI: 10.3390/ijms23094559.


DNA Adduct Assessment During Antihormonal Treatment of Perianal Gland Tumors With Tamoxifen in Male Dogs.

Brodzki A, Tatara M, Brodzki P, Balicki I In Vivo. 2019; 33(3):731-735.

PMID: 31028190 PMC: 6559889. DOI: 10.21873/invivo.11532.


Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions.

Pottenger L, Boysen G, Brown K, Cadet J, Fuchs R, Johnson G Environ Mol Mutagen. 2018; 60(2):100-121.

PMID: 30536466 PMC: 6590209. DOI: 10.1002/em.22248.


The formation and biological significance of N7-guanine adducts.

Boysen G, Pachkowski B, Nakamura J, Swenberg J Mutat Res. 2009; 678(2):76-94.

PMID: 19465146 PMC: 2739241. DOI: 10.1016/j.mrgentox.2009.05.006.


Risk assessment of low-level chemical exposures from consumer products under the U.S. Consumer Product Safety Commission chronic hazard guidelines.

BABICH M Environ Health Perspect. 1998; 106 Suppl 1:387-90.

PMID: 9539035 PMC: 1533264. DOI: 10.1289/ehp.98106s1387.